4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-25-331162
Chief Financial Officer sold 10,000 shares at an average $55.95 ($559,549)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Prasad Raju · Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-22 | Sale : show line 1 in the form 10b5-1 | −3,528 | $55.10 | $194,401 | 13,239 | D |
| 2025-12-22 | Sale : show line 2 in the form 10b5-1 | −5,472 | $56.33 | $308,262 | 7,767 | D |
| 2025-12-22 | Sale : show line 3 in the form 10b5-1 | −1,000 | $56.89 | $56,886 | 6,767 | D |
| Open-market sales · 10,000 sh · avg $55.95 · $559,549 | ||||||
Loading xslF345X05/ownership.xml…